Combating COVID-19: Generic Antibodies Can Be Retrained to Recognize SARS-CoV-2

The SARS-CoV-2, the new coronavirus behind the current pandemic, infects humans by binding its surface-exposed spike proteins to ACE2 receptors exposed on the cell membranes....
The post Combating COVID-19: Generic Antibodies Can Be Retrained to Recognize SARS-CoV-2 appeared first on SciTechDaily.